AI Market Research for Genomics & Precision Medicine

Analyze DNA sequencing cost curves, gene therapy pipelines, pharmacogenomics adoption, and direct-to-consumer genetic testing dynamics with AI-powered research.

Research the Genomics Market See a Sample Report

3 free analyses every month — no credit card required.

One platform · 100+ industries with specialized research data points

Real Estate SaaS Crypto Healthcare Fintech E-commerce Clean Energy Artificial Intelligence Logistics + 90 more

Simple Process

How It Works

From question to professional report in three steps.

Chat

Tell the AI about your market, product, or research question.

Generate

Our dual-AI engine researches, verifies, and compiles your report.

Download

Get a professional PDF — edit it further or share it immediately.

What You Get

Built for Genomics & Precision Medicine Professionals

Every feature is designed to give genomics & precision medicine teams an unfair research advantage.

Sequencing Cost Analysis

Track whole-genome sequencing cost curves, long-read vs. short-read economics, and sequencing-as-a-service platform growth.

Gene Therapy Pipeline

Research approved gene therapies, clinical trial pipelines, manufacturing scalability challenges, and pricing frameworks.

Pharmacogenomics Adoption

Analyze clinical pharmacogenomic testing adoption, payer coverage trends, and integration into electronic health records.

DTC Genetic Testing Dynamics

Compare 23andMe, AncestryDNA, and emerging platforms by subscriber growth, health feature adoption, and data monetization.

See it before you sign up

Real reports. Not a feature list.

Every plan produces a clean, citable document. Pro reports go deep — full market sizing, SWOT, Porter's Five Forces, charts and tables, with academic-grade citations — and you can edit and brand every page.

Edit and restructure any section after generation
Charts, tables & data visualizations baked in
SWOT + Porter's Five Forces frameworks
Export branded, print-ready PDFs

Try the PDF Editor

Market Categories

~5 min

Avg. Report Time

Dual AI

Verification Engine

Privacy Guarantee

Pricing

Simple, Transparent Pricing

Free

$0/month

3 Standard reports

See Free Plan

Basic

$8/month

Full PDF editor + 3 Standard reports

See Basic Plan

Paid

$13/month

12 Standard + 1 Pro

Get Started with Paid

Professional

$36/month

20 Standard + 5 Pro

See Professional Plan

Need custom limits? Contact us for Business plans →

About Us

Built by researchers, for researchers

We started RabbitReport because we were tired of paying six figures for research tools that still required hours of manual work. We built the platform we wished existed.

Our Mission

To make world-class market intelligence accessible to every founder, analyst, and team — not just the ones with enterprise-sized budgets.

Russell F.

Founder & CEO

Built RabbitReport to make professional market intelligence accessible to every founder, analyst, and business — without the six-figure price tag.

Baleigh S.

Lead Marketer

Drives growth strategy and brand voice for RabbitReport, helping analysts and founders discover smarter research tools.

AI-Powered Market Research

Research smarter,
report faster.

Join professionals and founders who make better decisions with AI-powered market research.

Get Started Free

Stay ahead of the market

Sign up for our newsletter to get the latest product updates, market insights, and exclusive offers delivered straight to your inbox.

The Genomics & Precision Medicine Market at a Glance

Genomics and precision medicine combine sequencing technology, multi-omics, bioinformatics, and targeted therapeutics to tailor diagnosis and treatment to individual molecular profiles. The value chain runs from sequencing instruments and reagents through cloud-based analysis pipelines to companion diagnostics, gene and cell therapies, and population-scale biobanks. Customers include academic and pharmaceutical research, clinical labs, oncology and rare-disease practices, and increasingly direct consumers. Plummeting sequencing costs, CRISPR-based editing, and AI-driven variant interpretation are the core demand drivers, alongside the shift toward biomarker-stratified clinical trials. Structurally, the field is shaped by reimbursement uncertainty, evolving regulatory pathways for gene therapies, and concentration among a few sequencing-platform suppliers. Liquid biopsy for early cancer detection, approved CRISPR therapeutics, and the integration of genomic data into routine care are pushing the sector from research toward clinical and consumer scale.

Trend 1

CRISPR therapies reach clinic

Approved gene-editing treatments for blood disorders are validating in vivo and ex vivo editing, opening pipelines across rare and common diseases.

Trend 2

Liquid biopsy early detection

Blood-based tests detecting circulating tumor DNA are advancing toward multi-cancer early screening, reshaping oncology diagnostics and reimbursement debates.

Trend 3

AI-driven variant interpretation

Machine learning is accelerating annotation of genomic variants and drug-target discovery, compressing the bottleneck between sequencing and actionable clinical insight.

Genomics & Precision Medicine Market Research — Frequently Asked Questions

Common questions about generating genomics & precision medicine market analysis and industry reports with RabbitReport. Each report is produced by AI, cross-checked with dual-AI verification, and delivered as a professional document in minutes — so you can move from question to insight without weeks of manual research.

What does a genomics and precision medicine market report cover?

A genomics market analysis examines the field's trends, competitors, and dynamics, including DNA sequencing cost curves, gene therapy pipelines, pharmacogenomics adoption, and direct-to-consumer genetic testing. RabbitReport assembles these sub-topics into a structured, professional report so you can understand how precision medicine is advancing and where the competitive opportunities lie.

How does RabbitReport analyze the genomics market?

RabbitReport generates an AI-driven genomics and precision medicine analysis, then runs a second, independent AI verification over the findings. This dual-AI approach helps produce more reliable insight on topics like sequencing economics, gene therapy clinical pipelines, and pharmacogenomics integration, supporting better-informed decisions in a complex scientific field.

Who uses genomics and precision medicine research reports?

Biotech founders, life-science investors, R&D strategists, and healthcare consultants use these reports to track a rapidly evolving market. Whether you are evaluating gene therapy pipelines, the trajectory of sequencing costs, or direct-to-consumer testing dynamics, a market analysis report helps frame competitive positioning around verifiable, evergreen trends.

How quickly can I get a genomics market report?

You can generate a genomics report in minutes. After you specify the topic, such as gene therapy or pharmacogenomics adoption, the tool produces a professional, PDF-style document covering the market's trends and players. A free tier is available so you can try the experience before scaling your precision medicine research.